GABA systems, benzodiazepines, and substance dependence

Journal of Clinical Psychiatry

Volumn 64, Issue SUPPL. 3, 2003, Pages 36-40

  Malcolm, Robert J ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MUSC Center for Drug and Alcohol Programs   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; ALCOHOL; AMITRIPTYLINE; BACLOFEN; BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR; CALCIUM; CARBAMAZEPINE; COCAINE; DIAZEPAM; DOPAMINE; FELBAMATE; FREE RADICAL; GABAPENTIN; GABATRIL; HYPNOTIC SEDATIVE AGENT; LORAZEPAM; LORECLEZOLE; LOSIGAMONE; MIDAZOLAM; PEROXIDASE; PROGABIDE; PSYCHOSTIMULANT AGENT; REMACEMIDE; SEROTONIN; SODIUM; STIRIPENTOL; TIAGABINE; UNINDEXED DRUG; VIGABATRIN;

ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ATAXIA; BINDING SITE; BLOOD TOXICITY; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; CONFUSION; DETOXIFICATION; DOWN REGULATION; GABAERGIC SYSTEM; HUMAN; KINDLING; LIVER INJURY; MOTOR DYSFUNCTION; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RELAPSE; REVIEW; SUBSTANCE ABUSE; VERTIGO; WITHDRAWAL SYNDROME;

ALCOHOL DRINKING; ALCOHOL-RELATED DISORDERS; BENZODIAZEPINES; GAMMA-AMINOBUTYRIC ACID; HUMANS; HYPNOTICS AND SEDATIVES; MODELS, PSYCHOLOGICAL; RECEPTORS, GABA; RECURRENCE; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; SYNAPTIC TRANSMISSION;

EID: 0037237413     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Caetano R, Cunradi C. Alcohol dependence: a public health perspective. Addiction 2002;97:633-645
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
3. Becker HC. Alcohol withdrawal: neuroadaptation and sensitization. CNS Spectrums 1999;4:38-65
4. Tsai GE, Ragan P, Chang R, et al. Increased glutamatergic neurotransmission and oxidative stress after alcohol withdrawal. Am J Psychiatry 1998; 155:726-732
5. Freund G, Ballinger WE. Loss of synaptic receptors can precede morphologic changes induced by alcoholism. Alcohol Alcohol Suppl 1991;1: 385-391
6. Ballenger JC, Post RM. Kindling as a model for alcohol withdrawal syndrome. Br J Psychiatry 1978;133:1-14
7. Becker JC, Hale RL. Repeated episodes of ethanol withdrawal potentiate the severity of subsequent withdrawal seizures: an animal model of alcohol withdrawal "kindling." Alcohol Clin Exp Res 1993;17:94-98
8. Lundqvist C, Alling C, Knoth R, et al. Intermittent ethanol exposure of adult rats: hippocampal cell loss after one month of treatment. Alcohol Alcohol 1995;30:737-748
9. Lundqvist C, Volk B, Knoth R, et al. Long-term effects of intermittent versus continuous ethanol exposure on hippocampal synapses of the rat. Acta Neuropathol 1994;87:242-249
10. Pieninkeroinen IP, Telakivi TM, Hillbom ME. Outcome in subjects with alcohol-provoked seizures. Alcohol Clin Exp Res 1992;16:955-959
11. Brown ME, Anton RF, Malcolm R, et al. Alcoholic detoxification and with-drawal seizures: clinical support for a kindling hypothesis. Biol Psychiatry 1988;23:507-514
12. Shaw GK, Waller S, Latham CJ, et al. The detoxification experience of alcoholic inpatients and predictors of outcome. Alcohol Alcohol 1998;33: 291-303
13. Koski A, Ojanperä I, Vuori E. Alcohol and benzodiazepines in fatal poisonings. Alcohol Clin Exp Res 2002;26:956-959
14. Booth BM, Blow FC. The kindling hypothesis: further evidence from a U.S. national survey of alcoholic men. Alcohol Alcohol 1993;28: 593-598
15. Malcolm R, Roberts JS, Wang W, et al. Multiple previous detoxifications are associated with less responsive treatment and heavier drinking during an index outpatient detoxification. Alcohol 2000;22:59-164
16. Malcolm R, Myrick H, Roberts J, et al. The differential effects of medication of mood, sleep disturbance, and work ability in outpatient alcohol detoxification. Am J Addict 2002;11:141-150
17. Malcolm R, Myrick H, Roberts J, et al. The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial. J Gen Intern Med 2002;17:1-7
18. O'Connor PG, Gottlieb LD, Kraus ML, et al. Social and clinical features as predictors of outcome in outpatient alcohol withdrawal. J Gen Intern Med 1991;6:312-316
19. Deutsch JA, Walton NY. Diazepam maintenance of alcohol preference during alcohol withdrawal. Science 1977;198:307-309
20. Hedlund L, Wahlstrom G. The effect of diazepam on voluntary ethanol intake in a rat model of alcoholism. Alcohol Alcohol 1998;33:207-219
21. Söderpalm AH, Hansen S. Benzodiazepines enhance the consumption and palatability of alcohol in the rat. Psychopharmacology 1998;137:215-222
22. Kalivas PW, Stewart J. Dopamine transmission in the initiation and expression of drug and stress-induced sensitization of motor activity. Brain Res Rev 1991;16:223-244
23. Krupitsky EM, Burakov AM, Ivanov VB, et al. Baclofen administration for the treatment of affective disorders in alcoholic patients. Drug Alcohol Depend 1996;15:417-423
24. Addolorato G, Caputo F, Capristo E, et al. Rapid suppression of alcohol withdrawal syndrome by baclofen. Am J Med 2002;112:226-229
25. Meldrum BS, Chapman AG. Basic mechanisms of gabatril (tiagabine) and future potential developments. Epilepsia 1999;40(suppl 9):S2-S6
26. Cleton A, Altorf BA, Voskuyl RA, et al. Effect of amygdala kindling on the central nervous system of tiagabine: EEG effects versus brain GABA levels. Br J Pharmacol 2000;130:1037-1044
27. Kastberg H, Jansen JA, Cole G, et al. Tiagabine: absence of kinetic or dynamic interactions with ethanol. Drug Metabol Drug Interact 1998;14: 259-273
28. Winhusen T, Somoza E, Goldsmith J, et al. A NIDA-sponsored clinical rapid efficacy screening trial (CREST) of tiagabine, sertraline, and donezepil. Drug Alcohol Depend 2001;63(suppl 1):S170-S171
29. Schmitt U, Waldhofer S, Weigelt T, et al. Free-choice ethanol consumption under the influence of GABAergic drugs in rats. Alcohol Clin Exp Res 2002;26:457-462
30. Gasior MJ, Ungard JT, Witkin JM. Preclinical evaluation of newly approved and potential antiepileptic drugs against cocaine-induced seizures. J Pharmacol Exp Ther 1999;290:1148-1156
31. Bamas C, Rossmann M, Roessler H, et al. Benzodiazepines and other psychotropic drugs abused by patients in a methadone maintenance program: familiarity and preference. J Clin Psychopharmacol 1992;12:397-402
32. Griffiths RR, Wolf B. Relative abuse potential of different benzodiazepines in drug abusers. J Clin Psychopharmacol 1990;10:237-243
33. Ling W, Shoptaw S, Majewska D. Baclofen as a cocaine anti-craving medication: a preliminary clinical study. Neuropsychopharmacology 1998;18: 403-404
34. Roberts DC, Andrews MM, Vickers GJ. Baclofen attenuates the reinforcing effects of cocaine in rats. Neuropsychopharmacology 1996;15: 417-423